Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 13, 2023

BUY
$29.44 - $37.31 $232,311 - $294,413
7,891 New
7,891 $269,000
Q4 2022

Feb 03, 2023

SELL
$29.44 - $37.31 $75,896 - $96,185
-2,578 Reduced 24.63%
7,891 $269,000
Q3 2022

Oct 26, 2022

BUY
$28.84 - $38.92 $97,623 - $131,744
3,385 Added 47.78%
10,469 $318,000
Q2 2022

Aug 08, 2022

SELL
$33.25 - $45.11 $7,082 - $9,608
-213 Reduced 2.92%
7,084 $264,000
Q1 2022

May 12, 2022

SELL
$40.68 - $49.72 $234,886 - $287,083
-5,774 Reduced 44.17%
7,297 $331,000
Q4 2021

Jan 25, 2022

SELL
$43.21 - $57.6 $11,450 - $15,264
-265 Reduced 1.99%
13,071 $629,000
Q3 2021

Nov 04, 2021

SELL
$52.8 - $60.32 $58,819 - $67,196
-1,114 Reduced 7.71%
13,336 $741,000
Q2 2021

Aug 09, 2021

SELL
$51.29 - $59.15 $1,025 - $1,183
-20 Reduced 0.14%
14,450 $784,000
Q1 2021

May 14, 2021

BUY
$42.18 - $56.07 $6,284 - $8,354
149 Added 1.04%
14,470 $811,000
Q4 2020

Feb 09, 2021

SELL
$35.18 - $43.52 $328,651 - $406,563
-9,342 Reduced 39.48%
14,321 $623,000
Q3 2020

Nov 05, 2020

BUY
$37.98 - $48.72 $401,524 - $515,067
10,572 Added 80.76%
23,663 $921,000
Q2 2020

Jul 30, 2020

BUY
$31.07 - $44.74 $406,737 - $585,691
13,091 New
13,091 $566,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.